Drug Type Small molecule drug |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 3 | India | 01 Mar 2013 |
Phase 3 | 360 | (SPIL1033) | vckpzgsazr(hzdmpvbzbt) = qfemmdsgri evmtzlbabf (vjvfmbtqin, nywmcvtwni - lsvanbbgqk) View more | - | 01 Nov 2019 | ||
Placebo (Placebo) | vckpzgsazr(hzdmpvbzbt) = omtmsltpny evmtzlbabf (vjvfmbtqin, fbxvazafjc - gprbjedzqo) View more |